185 related articles for article (PubMed ID: 16108385)
1. [Progress of EBNA1/oriP-based plasmid applied in gene therapy].
He J; Zhang ZQ
Sheng Wu Gong Cheng Xue Bao; 2005 May; 21(3):507-10. PubMed ID: 16108385
[TBL] [Abstract][Full Text] [Related]
2. Improvement of nonviral gene therapy by Epstein-Barr virus (EBV)-based plasmid vectors.
Mazda O
Curr Gene Ther; 2002 Sep; 2(3):379-92. PubMed ID: 12189722
[TBL] [Abstract][Full Text] [Related]
3. An enhanced EBNA1 variant with reduced IR3 domain for long-term episomal maintenance and transgene expression of oriP-based plasmids in human cells.
Wendelburg BJ; Vos JM
Gene Ther; 1998 Oct; 5(10):1389-99. PubMed ID: 9930345
[TBL] [Abstract][Full Text] [Related]
4. Significant antitumor effects obtained by autologous tumor cell vaccine engineered to secrete interleukin (IL)-12 and IL-18 by means of the EBV/lipoplex.
Asada H; Kishida T; Hirai H; Satoh E; Ohashi S; Takeuchi M; Kubo T; Kita M; Iwakura Y; Imanishi J; Mazda O
Mol Ther; 2002 May; 5(5 Pt 1):609-16. PubMed ID: 11991752
[TBL] [Abstract][Full Text] [Related]
5. Targeted killing of carcinoembryonic antigen (CEA)-producing cholangiocarcinoma cells by polyamidoamine dendrimer-mediated transfer of an Epstein-Barr virus (EBV)-based plasmid vector carrying the CEA promoter.
Tanaka S; Iwai M; Harada Y; Morikawa T; Muramatsu A; Mori T; Okanoue T; Kashima K; Maruyama-Tabata H; Hirai H; Satoh E; Imanishi J; Mazda O
Cancer Gene Ther; 2000 Sep; 7(9):1241-50. PubMed ID: 11023196
[TBL] [Abstract][Full Text] [Related]
6. Up to 100-fold increase of apparent gene expression in the presence of Epstein-Barr virus oriP sequences and EBNA1: implications of the nuclear import of plasmids.
Längle-Rouault F; Patzel V; Benavente A; Taillez M; Silvestre N; Bompard A; Sczakiel G; Jacobs E; Rittner K
J Virol; 1998 Jul; 72(7):6181-5. PubMed ID: 9621086
[TBL] [Abstract][Full Text] [Related]
7. HCF1 and OCT2 Cooperate with EBNA1 To Enhance OriP-Dependent Transcription and Episome Maintenance of Latent Epstein-Barr Virus.
Dheekollu J; Wiedmer A; Sentana-Lledo D; Cassel J; Messick T; Lieberman PM
J Virol; 2016 Jun; 90(11):5353-5367. PubMed ID: 27009953
[TBL] [Abstract][Full Text] [Related]
8. Structural and Functional Basis for an EBNA1 Hexameric Ring in Epstein-Barr Virus Episome Maintenance.
Deakyne JS; Malecka KA; Messick TE; Lieberman PM
J Virol; 2017 Oct; 91(19):. PubMed ID: 28701406
[TBL] [Abstract][Full Text] [Related]
9. Ribosome Protein L4 is essential for Epstein-Barr Virus Nuclear Antigen 1 function.
Shen CL; Liu CD; You RI; Ching YH; Liang J; Ke L; Chen YL; Chen HC; Hsu HJ; Liou JW; Kieff E; Peng CW
Proc Natl Acad Sci U S A; 2016 Feb; 113(8):2229-34. PubMed ID: 26858444
[TBL] [Abstract][Full Text] [Related]
10. The linking regions of EBNA1 are essential for its support of replication and transcription.
Mackey D; Sugden B
Mol Cell Biol; 1999 May; 19(5):3349-59. PubMed ID: 10207059
[TBL] [Abstract][Full Text] [Related]
11. Establishment and applications of epstein-barr virus-based episomal vectors in human embryonic stem cells.
Ren C; Zhao M; Yang X; Li D; Jiang X; Wang L; Shan W; Yang H; Zhou L; Zhou W; Zhang H
Stem Cells; 2006 May; 24(5):1338-47. PubMed ID: 16410388
[TBL] [Abstract][Full Text] [Related]
12. Pleiotrophic functions of Epstein-Barr virus nuclear antigen-1 (EBNA-1) and oriP differentially contribute to the efficiency of transfection/expression of exogenous gene in mammalian cells.
Kishida T; Asada H; Kubo K; Sato YT; Shin-Ya M; Imanishi J; Yoshikawa K; Mazda O
J Biotechnol; 2008 Jan; 133(2):201-7. PubMed ID: 17935815
[TBL] [Abstract][Full Text] [Related]
13. Epstein-Barr Nuclear Antigen 1 modulates replication of oriP-plasmids by impeding replication and transcription fork migration through the family of repeats.
Aiyar A; Aras S; Washington A; Singh G; Luftig RB
Virol J; 2009 Mar; 6():29. PubMed ID: 19265546
[TBL] [Abstract][Full Text] [Related]
14. Metaphase chromosome tethering is necessary for the DNA synthesis and maintenance of oriP plasmids but is insufficient for transcription activation by Epstein-Barr nuclear antigen 1.
Sears J; Kolman J; Wahl GM; Aiyar A
J Virol; 2003 Nov; 77(21):11767-80. PubMed ID: 14557661
[TBL] [Abstract][Full Text] [Related]
15. Efficient replication of Epstein-Barr virus-derived plasmids requires tethering by EBNA1 to host chromosomes.
Hodin TL; Najrana T; Yates JL
J Virol; 2013 Dec; 87(23):13020-8. PubMed ID: 24067969
[TBL] [Abstract][Full Text] [Related]
16. B Cell-Specific Transcription Activator PAX5 Recruits p300 To Support EBNA1-Driven Transcription.
Liu CD; Lee HL; Peng CW
J Virol; 2020 Mar; 94(7):. PubMed ID: 31941781
[TBL] [Abstract][Full Text] [Related]
17. Replication licensing of the EBV oriP minichromosome.
Hirai K; Shirakata M
Curr Top Microbiol Immunol; 2001; 258():13-33. PubMed ID: 11443858
[TBL] [Abstract][Full Text] [Related]
18. BZLF1 controlled by family repeat domain induces lytic cytotoxicity in Epstein-Barr virus-positive tumor cells.
Wang H; Zhao Y; Zeng L; Tang M; El-Deeb A; Li JJ; Cao Y
Anticancer Res; 2004; 24(1):67-74. PubMed ID: 15015577
[TBL] [Abstract][Full Text] [Related]
19. Chromatin-binding regions of EBNA1 protein facilitate the enhanced transfection of Epstein-Barr virus-based vectors.
Howden SE; Wardan H; Voullaire L; McLenachan S; Williamson R; Ioannou P; Vadolas J
Hum Gene Ther; 2006 Aug; 17(8):833-44. PubMed ID: 16942443
[TBL] [Abstract][Full Text] [Related]
20. Effective suicide gene therapy in vivo by EBV-based plasmid vector coupled with polyamidoamine dendrimer.
Maruyama-Tabata H; Harada Y; Matsumura T; Satoh E; Cui F; Iwai M; Kita M; Hibi S; Imanishi J; Sawada T; Mazda O
Gene Ther; 2000 Jan; 7(1):53-60. PubMed ID: 10680016
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]